Stock DNA
Pharmaceuticals & Biotechnology
EUR 6 Million ()
NA (Loss Making)
NA
0.00%
-0.15
-17,204.13%
1.42
Revenue and Profits:
Net Sales:
189 Million
(Quarterly Results - Jun 2019)
Net Profit:
-346 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.75%
0%
12.75%
6 Months
-3.36%
0%
-3.36%
1 Year
4.55%
0%
4.55%
2 Years
1.77%
0%
1.77%
3 Years
-30.56%
0%
-30.56%
4 Years
-64.62%
0%
-64.62%
5 Years
0%
0%
0.0%
International Care Co. SpA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
211.55%
EBIT Growth (5y)
-210.31%
EBIT to Interest (avg)
-5.27
Debt to EBITDA (avg)
6.19
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
60.00
Tax Ratio
12.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.16
EV to EBIT
-0.07
EV to EBITDA
0.08
EV to Capital Employed
1.15
EV to Sales
0.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1719.03%
ROE (Latest)
-15649.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'19 - YoY
Jun'19
Jun'18
Change(%)
Net Sales
189.00
55.90
238.10%
Operating Profit (PBDIT) excl Other Income
116.80
-11.00
1,161.82%
Interest
9.90
8.60
15.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-346.30
-35.90
-864.62%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2019 is 238.10% vs 31.53% in Jun 2018
Consolidated Net Profit
YoY Growth in quarter ended Jun 2019 is -864.62% vs -1,258.06% in Jun 2018
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
6.80
5.60
21.43%
Operating Profit (PBDIT) excl Other Income
-0.30
-0.30
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.90
-0.90
Operating Profit Margin (Excl OI)
-156.20%
-179.30%
2.31%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 21.43% vs 21.74% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 0.00% vs -800.00% in Dec 2022
About International Care Co. SpA 
International Care Co. SpA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






